[Japan] Nipro Injects Innovation Into Pre-Filled Syringes And Targets Us Expansion

Medical devices, pharmaceuticals and glass packaging products are the forte of the Nipro Corporation, who is well positioned to benefit from the rising global pre-filled syringes market, which accounted for US$3.9bn in 2014 and is expected to grow with a CAGR of 12.9% during 2015-2020. In this article, Yoshihiko Sano, President, explains how the company is on track to hit its ambitious growth targets for 2020, its corporate culture of innovation, and its commitment to improve the working lives of medical staff and the healthy life expectations of people worldwide.